Telomir Pharmaceuticals I... (TELO)
NASDAQ: TELO
· Real-Time Price · USD
1.50
0.01 (0.67%)
At close: Aug 18, 2025, 3:59 PM
1.45
-3.22%
Pre-market: Aug 19, 2025, 08:25 AM EDT
Telomir Pharmaceuticals Common Stock Revenue
Telomir Pharmaceuticals Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Telomir Pharmaceuticals Common Stock generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
1
Market Cap
46.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | n/a |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |